Blocking CCR5 activity by maraviroc augmentation in post-stroke depression: a proof-of-concept clinical trial
Abstract Background Post-stroke depression (PSD) is a significant impediment to successful rehabilitation and recovery after a stroke. Current therapeutic options are limited, leaving an unmet demand for specific and effective therapeutic options. Our objective was to investigate the safety of Marav...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2024-06-01
|
| coleção: | BMC Neurology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12883-024-03683-3 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|